The Research Edge
Institutional Investors
Pay Premium For
Marlowe Research delivers the analytical depth and independent insights that consistently outperform sell-side research from Goldman Sachs, Morgan Stanley, and JPMorgan.
Why Leading Institutions Choose Marlowe
Independent & Conflict-Free
- No investment banking relationships
- No trading desk conflicts
- Pure research focus
- Aligned only with client success
Institutional Depth
- 40+ page research reports
- Proprietary financial models
- Primary research & expert networks
- Quarterly earnings deep-dives
Proven Alpha Generation
- 73% outperformance rate
- 840 bps average alpha
- 18-month average holding period
- Track record since 2008
How Marlowe Compares to Sell-Side Research
A transparent comparison across the dimensions that matter most to institutional investors.
| Dimension | Marlowe Research | Goldman Sachs | Morgan Stanley | JPMorgan |
|---|---|---|---|---|
| Report Depth | 40+ pages | 15-20 pages | 12-18 pages | 15-20 pages |
| Conflicts of Interest | None | High | High | High |
| Client Access | Unlimited | Limited | Limited | Limited |
| Custom Research | Included | Extra fee | Extra fee | Extra fee |
| Model Transparency | Full access | Limited | Limited | Limited |
| Analyst Availability | Direct access | Restricted | Restricted | Restricted |
| Pricing Transparency | Clear | Opaque | Opaque | Opaque |
Recent Research Highlights
NVDA: Semiconductor Leadership
NVIDIA's dominance in AI computing infrastructure continues to accelerate, with data center revenue exceeding expectations.
JPM: Banking Sector Resilience
JPMorgan's diversified revenue streams and fortress balance sheet position it well for the current rate environment.
MSFT: Cloud Growth Acceleration
Microsoft Azure continues to gain market share with AI integration driving enterprise adoption at unprecedented rates.
Our Research Team
Dr. Sarah Chen, CFA
Managing Director, Technology Research
15 years at Goldman Sachs, PhD Stanford
Expertise: Software, Semiconductors, Cloud Computing
#1 Ranked Tech Analyst (Institutional Investor, 2023-2025)
Michael Rodriguez, CFA
Managing Director, Financial Services
18 years at Morgan Stanley, MBA Wharton
Expertise: Banks, Asset Managers, Fintech
#2 Ranked Financials Analyst (Institutional Investor, 2024)
Dr. Emily Watson
Director, Healthcare Research
12 years at Evercore ISI, MD/PhD Harvard
Expertise: Biotech, Pharmaceuticals, Med Tech
#3 Ranked Healthcare Analyst (StarMine, 2025)
James Park, CFA
Director, Consumer & Retail
14 years at JPMorgan, MBA Columbia
Expertise: E-commerce, Consumer Brands, Retail
Top 5 Consumer Analyst (TipRanks, 2024-2025)
Proprietary Research Methodology
Seven trademarked analytical frameworks that provide the foundation for our institutional-grade research.
Marlowe Competitive Moat Analysis™
Quantifies sustainable competitive advantages with a 15-factor scoring system
Marlowe Quality Score™
Evaluates management quality and governance across 20+ metrics in 5 dimensions
Marlowe Growth Framework™
Projects revenue growth with 95% confidence intervals and probability-weighted scenarios
Marlowe Valuation Matrix™
Multi-method valuation: DCF, comparables, and precedent transactions
Marlowe Risk Assessment™
Comprehensive risk quantification across 30+ factors in 6 categories
Marlowe Catalyst Tracker™
Identifies and monitors value catalysts with timeline and probability estimates
Marlowe Sentiment Indicator™
Tracks institutional positioning for contrarian opportunity identification
Membership Qualification
Marlowe Research maintains a strict client limit to ensure exceptional service quality and protect research edge.
Hedge Funds
- $500M+ AUM
- Fundamental long/short or long-only strategy
- 3+ year track record
- Institutional-quality operations
Asset Managers
- $1B+ AUM
- Active equity management
- Demonstrated alpha generation
- Commitment to independent research
All research, models, analyst access, custom projects
Selected sector coverage with analyst access
This report is for informational purposes only and does not constitute investment advice. Marlowe Research provides independent analysis for institutional investors. Past performance is not indicative of future results.